V001-1831 Screening compound: N-[1-(2-chloroacetyl)piperidin-4-yl]-N-[(3-chlorophenyl)methyl]-2-[N-(2-methoxyethyl)propane-1-sulfonamido]acetamide

V001-1831 Screening compound: N-[1-(2-chloroacetyl)piperidin-4-yl]-N-[(3-chlorophenyl)methyl]-2-[N-(2-methoxyethyl)propane-1-sulfonamido]acetamide
V001-1831 Screening compound: N-[1-(2-chloroacetyl)piperidin-4-yl]-N-[(3-chlorophenyl)methyl]-2-[N-(2-methoxyethyl)propane-1-sulfonamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-1831
N-[1-(2-chloroacetyl)piperidin-4-yl]-N-[(3-chlorophenyl)methyl]-2-[N-(2-methoxyethyl)propane-1-sulfonamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-1831

Molecular Formula

C22H33Cl2N3O5S (C22 H33 Cl2 N3 O5 S)

Compound Name

N-[1-(2-chloroacetyl)piperidin-4-yl]-N-[(3-chlorophenyl)methyl]-2-[N-(2-methoxyethyl)propane-1-sulfonamido]acetamide

IUPAC name

N-[1-(2-chloroacetyl)piperidin-4-yl]-N-[(3-chlorophenyl)methyl]-2-[N-(2-methoxyethyl)propane-1-sulfonamido]acetamide

SMILES

CCCS(N(CCOC)CC(N(Cc1cccc(Cl)c1)C(CC1)CCN1C(CCl)=O)=O)(=O)=O

InChI

InChI=1S/C22H33Cl2N3O5S/c1-3-13-33(30,31)26(11-12-32-2)17-22(29)27(16-18-5-4-6-19(24)14-18)20-7-9-25(10-8-20)21(28)15-23/h4-6,14,20H,3,7-13,15-17H2,1-2H3

InChI Key

SXAZTJSCPOLVKY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19970927

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

522.49

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.120

Distribution Coefficient, logD

2.120

Water Solubility, LogSw

-2.93

Polar Surface Area

71.229

Acid Dissociation Constant (pKa)

21.96

Base Dissociation Constant (pKb)

-1.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

63.60

V001-1831 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with V001-1831 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-1831?
Check Price and Availability of V001-1831, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-1831 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-1831
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-1831
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-1831 available by request